drugset / Trial / NCT02909257

Motor-Sparing Femoral Nerve Block Dose

NCT02909257 ↗

Phase 4 Terminated 31 enrolled University of Chile
RandomizedParallel-groupDouble-blindSupportive care

Summary

Femoral nerve blocks are commonly used to provide pain control for total knee replacement, anterior cruciate ligament (ACL) reconstruction. Commonly employed local anesthetic concentrations result in motor block of the quadriceps and constitute an inherent risk factor for patient fall. The aim of this study is to determine the minimum effective concentration of bupivacaine in 90 % of patients (MEC90) required for a motor-sparing, successful sensory block of the femoral nerve.

Timeline

Start
2016-09
Primary completion
2017-12
Completion
2017-12

Outcome

Outcome not reported

Stopped: “inadequate methodology to determine primary outcome”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified — —

Indications